A Phase I, Randomised, Double-Blind, Placebo-Controlled,AscendingSingle- and Repeat-Dose Study of the Safety,Tolerability andPharmacokinetics of Orally Administered PRN473

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Jul 2019

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

13 Mar 2014 Status changed from recruiting to completed, as per Australian New Zealand Clinical Trials Registry.
21 Nov 2013 Planned number of patients changed from 106 to 114 as reported by Australian New Zealand Clinical Trials Registry.
12 Nov 2013 According to the Australian New Zealand Clinical Trials Registry record, the anticipated date of last participant recruited/enrolled is 7/04/2014.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com